Navigation Links
Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published

the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statement

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in Amgen's Form 10-K for the year ended December 31, 2005, and in Amgen's periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects. In addition, sales of Amgen's products are affected by the availability of reimbursement and the reimbursement policies imposed by third party payors, including governments, private insurance plans and managed care providers, and may be affected by domestic and international trends toward managed care and healthcare cost containment as well as possible U.S. legislation affecting pharmaceutical pricing and reimbursement. Government regulations and reimbursement policies may affect the development, usage and pricing of Amgen's products. In addition, Amgen competes with other companies with respect to some of Amgen's marketed products as well as for the discovery and development of new products. Amgen believes that some of the newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Amgen products may compete against products that have lower prices, established reimbursement, superi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
2. Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal
3. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
4. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
5. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
6. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:4/1/2015)... WAYNE, Pa. , April 1, 2015 /PRNewswire/ ... fully integrated specialty pharmaceutical company focused on developing, ... the pricing of an offering of $60.0 million ... due 2020 (the "notes") in a private placement ... under the Securities Act of 1933, as amended ...
(Date:4/1/2015)... SAN CLEMENTE, Calif. , April 1, 2015 /PRNewswire/ ... residents in the United States ... out amongst their resident colleagues. In its inaugural year, ... and 50 of the top nominations were narrowed to ... voting process that saw over 10,000 votes from colleagues ...
(Date:4/1/2015)... CREEK, Calif. , April 1, 2015  For ... huge difference.  When this is the case, having the ... No one understands this truth better than software solutions ... laboratory management software QATrax.  Recently, the company announced the ... very enthusiastic response from clients. ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2
(Date:4/1/2015)... SCI Solutions , the health ... announced that CEO Joel French will be a featured ... Exhibition in Chicago, April 12-16, 2015. French will ... Care Coordination Strategies ” with Northeast Georgia Health System ... More than 38,000 healthcare industry professionals are expected at ...
(Date:4/1/2015)... 01, 2015 Dr Roz Kamani, a ... is now offering her patients an opportunity to learn ... participate in “Beauty Days”, which is an exclusive VIP ... Kamani’s Kitsilano Skin Care Clinic. It is attended by ... about the latest products and services that are on ...
(Date:4/1/2015)... GrassrootsHealth, an international nonprofit public ... education (CME) courses about vitamin D . ... confident in measuring, prescribing, and tracking vitamin D ... CME courses, practitioners can apply for D*certification with ... are “Vitamin D, Sunshine, Optimal Health: Putting it ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Tempaper has ... a new virtual giving campaign that will raise critical ... people fighting muscle disease across the United States. , ... MDA through Tempaperdesigns.com will automatically receive free ... bring strength and urgently needed progress to children and ...
(Date:4/1/2015)... April 01, 2015 Like a mosaic ... the scientific understanding of the potential causes of rosacea. ... the National Rosacea Society (NRS) to educate the public ... facial disorder now estimated to affect more than 16 ... medical research on rosacea through its patient-funded research grants ...
Breaking Medicine News(10 mins):Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5
... Sept. 12 The Tulsa World reports,that ... in Oklahoma City,today to promote his failed ... to a private closed door fundraiser for ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080519/DNCLOGO ), ...
... firm, today reports a hiring trend over the past four months ... realizing it is has become a “recruiters” market causing both parties ... ... September 12, 2008 -- Lucas Group, an executive search firm, today ...
... of their brand new tinnitus relief formula. ,T-Gone Tinnitus Remedies Inc. has ... one of the most reliable suppliers of tinnitus remedies. T-Gone tinnitus remedies ... battle against tinnitus. , ... Las Vegas, NV (PRWEB) September 12, 2008 ...
... of us yearn to wear the sheer, body-hugging fashions available ... sight of dreaded back fat rolls and lumps. A study ... Surgery , the official medical journal of the American Society ... that removes these unsightly bumps and bulges while hiding the ...
... ARAY ), a global leader in the field ... as chief financial,officer and senior vice president to pursue ... since March 2008, has been,appointed to serve as senior ... a successor is found., "Robert McNamara has been ...
... Sept. 11 ATS Medical, Inc.,(Nasdaq: ATSI ... and services, today announced that an unprecedented number,of ... Medical products,at the upcoming European Association for Cardio-Thoracic ... of cardiovascular surgeons from,around the world and is ...
Cached Medicine News:Health News:DNC: Bush-McCain Alert - President Touts Bush-McCain Health Care Agenda in Oklahoma 2Health News:DNC: Bush-McCain Alert - President Touts Bush-McCain Health Care Agenda in Oklahoma 3Health News:Lucas Group Reports Hiring Trend in High-Tech Medical Device 2Health News:T-Gone Tinnitus Cures -- A Potent New Tinnitus Formula Released 2Health News:Say 'goodbye' to back fat rolls 2Health News:Accuray Incorporated Announces Resignation of Chief Financial Officer 2Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 2Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 3Health News:ATS Medical Products Featured Prominently in Scientific Presentations at European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting 4
... Inline Plus is an easy to use, full color ... monitor (either a computer or a television) sits on ... in. It has a built in SVGA adapter allowing ... the magnified image from the video magnifier is displayed ...
... portability together in one product. Flipperport consists ... color camera that captures the image, and ... the magnified image. This self contained, battery-operated ... and comfort. FlipperPort can easily connect with ...
... camera design enables people with low vision ... rotating the camera head, the user can ... any distance. Flipper is lightweight and can ... another. Simply roll the base and rotate ...
... vision to see objects at a distance, ... between. This battery operated system can be ... used as a desktop video magnifier when ... easy to use and requires no special ...
Medicine Products: